Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4933
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults ; volume:14 ; number:1 ; day:12 ; month:4 ; year:2017 ; pages:1-14 ; date:12.2017
Immunity & ageing ; 14, Heft 1 (12.4.2017), 1-14, 12.2017
- Creator
-
Fries, Louis
- Contributor
-
Shinde, Vivek
Stoddard, Jeffrey J.
Thomas, D. Nigel
Kpamegan, Eloi
Lu, Hanxin
Smith, Gale
Hickman, Somia P.
Piedra, Pedro
Glenn, Gregory M.
SpringerLink (Online service)
- DOI
-
10.1186/s12979-017-0090-7
- URN
-
urn:nbn:de:1111-201704285961
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fries, Louis
- Shinde, Vivek
- Stoddard, Jeffrey J.
- Thomas, D. Nigel
- Kpamegan, Eloi
- Lu, Hanxin
- Smith, Gale
- Hickman, Somia P.
- Piedra, Pedro
- Glenn, Gregory M.
- SpringerLink (Online service)
Other Objects (12)
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle
Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus
Das Respiratory Syncytial Virus (RSV): Epidemiologie, Klinik- und Labordiagnose
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan
Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine
Protective efficacy and immunogenicity of a combinatory DNA vaccine against influenza A virus and the respiratory syncytial virus
Respiratory-Syncytial-Virus (RSV)-induzierte unspezifische bronchiale Hyperreaktivität : tierexperimentelle Untersuchungen am Meerschweinchen
Antikörper-Entwicklung nach Respiratory-Syncytial-Virus-(RSV)-Infektion bei Frühgeborenen und Säuglingen
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle
Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus
Das Respiratory Syncytial Virus (RSV): Epidemiologie, Klinik- und Labordiagnose
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan
Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine
Protective efficacy and immunogenicity of a combinatory DNA vaccine against influenza A virus and the respiratory syncytial virus
Respiratory-Syncytial-Virus (RSV)-induzierte unspezifische bronchiale Hyperreaktivität : tierexperimentelle Untersuchungen am Meerschweinchen
Antikörper-Entwicklung nach Respiratory-Syncytial-Virus-(RSV)-Infektion bei Frühgeborenen und Säuglingen
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle
Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus
Das Respiratory Syncytial Virus (RSV): Epidemiologie, Klinik- und Labordiagnose
Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan
Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine
Protective efficacy and immunogenicity of a combinatory DNA vaccine against influenza A virus and the respiratory syncytial virus
Respiratory-Syncytial-Virus (RSV)-induzierte unspezifische bronchiale Hyperreaktivität : tierexperimentelle Untersuchungen am Meerschweinchen
Antikörper-Entwicklung nach Respiratory-Syncytial-Virus-(RSV)-Infektion bei Frühgeborenen und Säuglingen